Alfredo Nicosia
TitoloCitata daAnno
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
E Scarselli, H Ansuini, R Cerino, RM Roccasecca, S Acali, G Filocamo, ...
The EMBO journal 21 (19), 5017-5025, 2002
13192002
Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor
B Bartosch, A Vitelli, C Granier, C Goujon, J Dubuisson, S Pascale, ...
Journal of Biological Chemistry 278 (43), 41624-41630, 2003
7092003
The liver-specific transcription factor LF-B1 contains a highly diverged homeobox DNA binding domain
M Frain, G Swart, P Monaci, A Nicosia, S Stmpfli, R Frank, R Cortese
Cell 59 (1), 145-157, 1989
4571989
Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication
A Nicosia, M Perugini, C Franzini, MC Casagli, MG Borri, G Antoni, ...
Proceedings of the National Academy of Sciences 83 (13), 4631-4635, 1986
3721986
A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera.
A Folgori, R Tafi, A Meola, F Felici, G Galfre, R Cortese, P Monaci, ...
The EMBO journal 13 (9), 2236-2243, 1994
3381994
Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man
E Barnes, A Folgori, S Capone, L Swadling, S Aston, A Kurioka, J Meyer, ...
Science translational medicine 4 (115), 115ra1-115ra1, 2012
3292012
A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees
A Folgori, S Capone, L Ruggeri, A Meola, E Sporeno, BB Ercole, ...
Nature medicine 12 (2), 190, 2006
3122006
Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2
A Higginbottom, ER Quinn, CC Kuo, M Flint, LH Wilson, E Bianchi, ...
Journal of virology 74 (8), 3642-3649, 2000
2782000
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
DA Stanley, AN Honko, C Asiedu, JC Trefry, AW Lau-Kilby, JC Johnson, ...
Nature medicine 20 (10), 1126, 2014
2572014
A model for the hepatitis C virus envelope glycoprotein E2
AT Yagnik, A Lahm, A Meola, RM Roccasecca, BB Ercole, A Nicosia, ...
Proteins: Structure, Function, and Bioinformatics 40 (3), 355-366, 2000
2552000
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
KJ Ewer, GA O’Hara, CJA Duncan, KA Collins, SH Sheehy, ...
Nature communications 4, 2836, 2013
2192013
Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2
RM Roccasecca, H Ansuini, A Vitelli, A Meola, E Scarselli, S Acali, ...
Journal of virology 77 (3), 1856-1867, 2003
2172003
Two different liver‐specific factors stimulate in vitro transcription from the human alpha 1‐antitrypsin promoter.
P Monaci, A Nicosia, R Cortese
The EMBO journal 7 (7), 2075-2087, 1988
2071988
Chimpanzee adenovirus vector Ebola vaccine
JE Ledgerwood, AD DeZure, DA Stanley, EE Coates, L Novik, ME Enama, ...
New England Journal of Medicine 376 (10), 928-938, 2017
2062017
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
L Swadling, S Capone, RD Antrobus, A Brown, R Richardson, EW Newell, ...
Science translational medicine 6 (261), 261ra153-261ra153, 2014
1992014
Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross‐reacting with a large number of viral variants
G Puntoriero, A Meola, A Lahm, S Zucchelli, BB Ercole, R Tafi, ...
The EMBO journal 17 (13), 3521-3533, 1998
1911998
Prime-boost vectored malaria vaccines: progress and prospects
AVS Hill, A Reyes-Sandoval, G O’Hara, K Ewer, A Lawrie, A Goodman, ...
Human vaccines 6 (1), 78-83, 2010
1872010
Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species
S Colloca, E Barnes, A Folgori, V Ammendola, S Capone, A Cirillo, ...
Science translational medicine 4 (115), 115ra2-115ra2, 2012
1852012
Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage.
A Meola, P Delmastro, P Monaci, A Luzzago, A Nicosia, F Felici, ...
The Journal of Immunology 154 (7), 3162-3172, 1995
1821995
High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein
MT Catanese, R Graziani, T von Hahn, M Moreau, T Huby, G Paonessa, ...
Journal of virology 81 (15), 8063-8071, 2007
1782007
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20